27 participants
Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-10
- Start Date:
- 2023-08-17
- Completion:
- 2024-12-19
Conditions
- Major Depressive Disorder
- Depression
Interventions
- DRUG